SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ADVISORY RESEARCH INC 17,538$483,5230.07%
Polaris Capital Management, LLC 42,500$1,171,7250.06%
FRONTIER CAPITAL MANAGEMENT CO LLC 200,653$5,532,0030.06%
Keeley-Teton Advisors, LLC 15,800$435,6060.06%
FRANKLIN STREET ADVISORS INC /NC 20,140$5550.05%
Covestor Ltd 2,350$650.05%
Y-Intercept (Hong Kong) Ltd 16,131$444,7320.04%
Eagle Bay Advisors LLC 3,212$88,5550.04%
CHARTWELL INVESTMENT PARTNERS, LLC 35,139$9690.04%
EXCHANGE TRADED CONCEPTS, LLC 41,854$1,153,9150.03%
INGALLS & SNYDER LLC 24,688$6810.03%
Pictet Asset Management Holding SA 920,552$25,379,6190.03%
Newbridge Financial Services Group, Inc. 2,000$55,1400.03%
MARTINGALE ASSET MANAGEMENT L P 48,136$1,327,1100.03%
West Tower Group, LLC 1,950$53,7620.03%
FIRST NATIONAL BANK OF OMAHA 14,182$390,9970.02%
Petrus Trust Company, LTA 8,362$230,5400.02%
VICTORY CAPITAL MANAGEMENT INC 711,169$19,606,9300.02%
PITCAIRN CO 9,149$252,2380.02%
Trexquant Investment LP 30,009$827,3480.02%
External links

This page lists SUPERNUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view SUPERNUS PHARMACEUTICALS INC's shareholder history, click here.